Share on LinkedInShare on LinkedIn

ARTICLE · 14 JULY 2021

The Conundrum Around The "First User" Rule: Analysing Supreme Court's Decision In Neon Laboratories' Case

Khaitan & Co.
Khaitan & Co.
Contributor
Khaitan & Co.

Khaitan & Co.

Founded in 1911, Khaitan & Co is a heritage law firm that has been a trusted adviser to leading...

View firm profile
Explore more from Khaitan & Co.

The facts of the said case are as follows: the Plaintiff-Respondent, Medical Technologies Ltd is engaged in the business of manufacturing and marketing of pharmaceutical products.

IndiaIntellectual Property

The Supreme Court (SC) in its decision of 5 October 2015, in the matter of Neon Laboratories Ltd. v Medical Technologies Ltd and Ors (Neon Laboratories case), noted that "[T]he "first user" rule is a seminal part of the [Trade Marks] Act" and passed an order based upon the said principle, while deciding a trade mark dispute. In the present article, we aim to discuss the SC's interpretation of Section 34 of the Trade Marks Act, 1999 (TM Act) and the application of "first user" rule in the Neon Laboratories case.

The facts of the said case are as follows: the Plaintiff-Respondent, Medical Technologies Ltd (MTL) is engaged in the business of manufacturing and marketing of pharmaceutical products. MTL had been using the mark 'PROFOL' since the year 2000 and its predecessor-in-title had commenced use of the same in April 1998. When the Defendant-Appellant, Neon Laboratories Ltd (Neon) introduced the same generic drug under the trade mark 'ROFOL', MTL filed a suit for

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this document does not necessarily reflect the views / position of Khaitan & Co but remain solely those of the author(s). For any further queries or follow up, please contact Khaitan & Co at [email protected].

See more popular content from